Literature DB >> 17846203

Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high-field magnetic resonance spectroscopy.

M P Wattjes1, M Harzheim, G G Lutterbey, L Klotz, H H Schild, F Träber.   

Abstract

BACKGROUND AND
PURPOSE: Proton MR spectroscopy ((1)H-MR spectroscopy) is a well-established method for the in vivo investigation of the normal-appearing white matter (NAWM) in patients with multiple sclerosis (MS). Metabolic changes in NAWM are of special interest in patients with clinically isolated syndromes (CIS) suggestive of MS regarding further prognostic classifications. The purpose of this study was to investigate metabolic alterations in NAWM in patients with CIS with use of high-field (1)H-MR spectroscopy and to compare the results to those in patients with an early course of MS.
MATERIALS AND METHODS: With use of a 3T whole-body MR imaging system, single-voxel (1)H-MR spectroscopy (PRESS; TR: 2000 ms; TE: 38 ms and 140 ms) of the parietal NAWM was performed in 20 control subjects, 36 patients with CIS, and 12 patients with MS. Metabolite ratios and concentrations of N-acetylaspartate (tNAA), myo-inositol (mIns), choline, and total creatine (tCr) were determined.
RESULTS: Compared with the control group, mean NAWM mIns concentrations were significantly elevated in the MS group (4.56 mmol/L versus 3.75 mmol/L, P = .02) but not in the CIS group (4.04 mmol/L, P = .44). The higher concentration of mIns in the MS group was also reflected in the increased Ins/tCr ratio (P = .02). The mean NAWM tNAA was significantly decreased in both patient groups compared with the control group (CIS, 13.42 mmol/L, P = .02; MS, 12.77 mmol/L versus 14.51 mmol/L, P = .008).
CONCLUSIONS: A significant increase of the activity of the glial cells can only be observed in patients with an established diagnosis of MS but not in patients with CIS. Axonal damage occurs already during the first demyelinating episode in patients with CIS as well as in patients with definite MS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17846203      PMCID: PMC8134381          DOI: 10.3174/ajnr.A0594

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  44 in total

1.  Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic mr imaging criteria for multiple sclerosis?

Authors:  M P Wattjes; M Harzheim; C K Kuhl; J Gieseke; S Schmidt; L Klotz; T Klockgether; H H Schild; G G Lutterbey
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

2.  Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.

Authors:  J H Simon; D Li; A Traboulsee; P K Coyle; D L Arnold; F Barkhof; J A Frank; R Grossman; D W Paty; E W Radue; J S Wolinsky
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

3.  Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliability.

Authors:  D Wiedermann; N Schuff; G B Matson; B J Soher; A T Du; A A Maudsley; M W Weiner
Journal:  Magn Reson Imaging       Date:  2001-10       Impact factor: 2.546

4.  Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies.

Authors:  M L Simmons; C G Frondoza; J T Coyle
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

5.  MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5 T and 4 T.

Authors:  M D Keiper; R I Grossman; J A Hirsch; L Bolinger; I L Ott; L J Mannon; C P Langlotz; D L Kolson
Journal:  AJNR Am J Neuroradiol       Date:  1998-09       Impact factor: 3.825

6.  Imaging of inflammatory lesions at 3.0 Tesla in patients with clinically isolated syndromes suggestive of multiple sclerosis: a comparison of fluid-attenuated inversion recovery with T2 turbo spin-echo.

Authors:  Mike P Wattjes; Götz G Lutterbey; Michael Harzheim; Jürgen Gieseke; Frank Träber; Luisa Klotz; Thomas Klockgether; Hans H Schild
Journal:  Eur Radiol       Date:  2006-04-04       Impact factor: 5.315

Review 7.  Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis.

Authors:  D H Miller; A J Thompson; M Filippi
Journal:  J Neurol       Date:  2003-12       Impact factor: 4.849

8.  1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis.

Authors:  S M Leary; C A Davie; G J Parker; V L Stevenson; L Wang; G J Barker; D H Miller; A J Thompson
Journal:  J Neurol       Date:  1999-11       Impact factor: 4.849

9.  Java-based graphical user interface for the MRUI quantitation package.

Authors:  A Naressi; C Couturier; J M Devos; M Janssen; C Mangeat; R de Beer; D Graveron-Demilly
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.533

10.  Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis.

Authors:  P A Brex; B Gomez-Anson; G J Parker; P D Molyneux; K A Miszkiel; G J Barker; D G MacManus; C A Davie; G T Plant; D H Miller
Journal:  J Neurol Sci       Date:  1999-06-15       Impact factor: 3.181

View more
  22 in total

1.  Diagnostic and prognostic value of in vivo proton MR spectroscopy for Zellweger syndrome spectrum patients.

Authors:  H Rosewich; P Dechent; C Krause; A Ohlenbusch; K Brockmann; J Gärtner
Journal:  J Inherit Metab Dis       Date:  2016-08-03       Impact factor: 4.982

2.  Short-term cuprizone feeding verifies N-acetylaspartate quantification as a marker of neurodegeneration.

Authors:  Barbara Maria Krauspe; Wolfgang Dreher; Cordian Beyer; Werner Baumgartner; Bernd Denecke; Katharina Janssen; Claus-Dieter Langhans; Tim Clarner; Markus Kipp
Journal:  J Mol Neurosci       Date:  2014-09-05       Impact factor: 3.444

3.  Occurrence of neuronal dysfunction during the first 5 years of multiple sclerosis is associated with cognitive deterioration.

Authors:  Wafaa Zaaraoui; Françoise Reuter; Audrey Rico; Anthony Faivre; Lydie Crespy; Irina Malikova; Elisabeth Soulier; Patrick Viout; Yann Le Fur; Sylviane Confort-Gouny; Patrick J Cozzone; Jean Pelletier; Jean-Philippe Ranjeva; Bertrand Audoin
Journal:  J Neurol       Date:  2010-12-04       Impact factor: 4.849

4.  Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis.

Authors:  Mike P Wattjes; Michael Harzheim; Götz G Lutterbey; Manuela Bogdanow; Stephan Schmidt; Hans H Schild; Frank Träber
Journal:  Neuroradiology       Date:  2007-11-03       Impact factor: 2.804

5.  Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla.

Authors:  Fahmy Aboul-Enein; Martin Krssák; Romana Höftberger; Daniela Prayer; Wolfgang Kristoferitsch
Journal:  PLoS One       Date:  2010-07-20       Impact factor: 3.240

Review 6.  High field MRI in the diagnosis of multiple sclerosis: high field-high yield?

Authors:  Mike P Wattjes; Frederik Barkhof
Journal:  Neuroradiology       Date:  2009-03-11       Impact factor: 2.804

Review 7.  Proton magnetic resonance spectroscopy in multiple sclerosis.

Authors:  Balasrinivasa R Sajja; Jerry S Wolinsky; Ponnada A Narayana
Journal:  Neuroimaging Clin N Am       Date:  2009-02       Impact factor: 2.264

Review 8.  The prognostic utility of MRI in clinically isolated syndrome: a literature review.

Authors:  C Odenthal; A Coulthard
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-15       Impact factor: 3.825

9.  High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria.

Authors:  Mike P Wattjes; Michael Harzheim; Götz G Lutterbey; Manuela Bogdanow; Hans H Schild; Frank Träber
Journal:  J Neurol       Date:  2007-12-20       Impact factor: 4.849

10.  Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy.

Authors:  Emily T Wood; Itamar Ronen; Aranee Techawiboonwong; Craig K Jones; Peter B Barker; Peter Calabresi; Daniel Harrison; Daniel S Reich
Journal:  J Neurosci       Date:  2012-05-09       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.